Amniotics AB (publ) (STO:AMNI)

SolarWinds Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	2.45	-	-	-	-	-
Gross Profit	2.45	-	-	-	-	-
Selling, General & Admin	24.65	32.08	45.13	51.35	29.43	10.14
Other Operating Expenses	-5.69	-5.31	-0.23	0.11	-0.02	0
Operating Expenses	21.25	29.07	46.69	53.62	30.99	10.43
Operating Income	-18.8	-29.07	-46.69	-53.62	-30.99	-10.43
Interest Expense	-1.49	-1.9	-1.39	-0	-0	-0
Interest & Investment Income	0.1	0.1	0.04	-	-	-
Other Non Operating Income (Expenses)	0	0	-	-	-	-
Pretax Income	-20.19	-30.87	-48.05	-53.62	-31	-10.43
Net Income	-20.19	-30.87	-48.05	-53.62	-31	-10.43
Net Income to Common	-20.19	-30.87	-48.05	-53.62	-31	-10.43
Shares Outstanding (Basic)	4,131	2,806	16	16	-	-
Shares Outstanding (Diluted)	4,131	2,806	16	16	-	-
Shares Change (YoY)	9149.92%	17364.57%	0.10%	-	-	-
EPS (Basic)	-0.00	-0.01	-2.99	-3.34	-	-
EPS (Diluted)	-0.00	-0.01	-2.99	-3.34	-	-
Free Cash Flow	-19.74	-29.85	-47.05	-15.69	-66.81	-
Free Cash Flow Per Share	-0.00	-0.01	-2.93	-0.98	-	-
EBITDA	-16.89	-27.14	-44.9	-51.46	-29.41	-10.15
D&A For EBITDA	1.91	1.93	1.79	2.15	1.59	0.28
EBIT	-18.8	-29.07	-46.69	-53.62	-30.99	-10.43
Revenue as Reported	-	-	-	0.05	0.04	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.